Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development

J. Zilliacus; M. K. Draskau; H. K. Johansson; A. K. Rosenmai; S. Christiansen; E. Elmelund; M. L. Holmer; P. Damdimopoulou; E. M. Panagiotou; M. van Duursen; N. Bouftas; T. Svingen; A. Beronius

doi:10.1016/S0378-4274(23)00453-8

Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development

J. Zilliacus^*, M. K. Draskau, H. K. Johansson, A. K. Rosenmai, S. Christiansen, E. Elmelund, M. L. Holmer, P. Damdimopoulou, E. M. Panagiotou, M. van Duursen, N. Bouftas, T. Svingen, A. Beronius

^*Corresponding author for this work

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	P01-10
Journal	Toxicology Letters
Volume	384
Issue number	Supplement 1
Pages (from-to)	S77
ISSN	0378-4274
DOIs	https://doi.org/10.1016/S0378-4274(23)00453-8
Publication status	Published - 2023

Access to Document

10.1016/S0378-4274(23)00453-8

OpenUrl availability

Full text

Cite this

Zilliacus, J., Draskau, M. K., Johansson, H. K., Rosenmai, A. K., Christiansen, S., Elmelund, E., Holmer, M. L., Damdimopoulou, P., Panagiotou, E. M., van Duursen, M., Bouftas, N., Svingen, T., & Beronius, A. (2023). Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development. Toxicology Letters, 384(Supplement 1), S77. Article P01-10. https://doi.org/10.1016/S0378-4274(23)00453-8

@article{d3288133d5984e66bf8aec9f8667ca25,

title = "Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development",

author = "J. Zilliacus and Draskau, {M. K.} and Johansson, {H. K.} and Rosenmai, {A. K.} and S. Christiansen and E. Elmelund and Holmer, {M. L.} and P. Damdimopoulou and Panagiotou, {E. M.} and {van Duursen}, M. and N. Bouftas and T. Svingen and A. Beronius",

year = "2023",

doi = "10.1016/S0378-4274(23)00453-8",

language = "English",

volume = "384",

pages = "S77",

journal = "Toxicology Letters",

issn = "0378-4274",

publisher = "Elsevier",

number = "Supplement 1",

}

Zilliacus, J, Draskau, MK , Johansson, HK , Rosenmai, AK , Christiansen, S , Elmelund, E , Holmer, ML, Damdimopoulou, P, Panagiotou, EM, van Duursen, M, Bouftas, N, Svingen, T & Beronius, A 2023, 'Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development', Toxicology Letters, vol. 384, no. Supplement 1, P01-10, pp. S77. https://doi.org/10.1016/S0378-4274(23)00453-8

Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development. / Zilliacus, J.; Draskau, M. K.; Johansson, H. K. et al.
In: Toxicology Letters, Vol. 384, No. Supplement 1, P01-10, 2023, p. S77.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development

AU - Zilliacus, J.

AU - Draskau, M. K.

AU - Johansson, H. K.

AU - Rosenmai, A. K.

AU - Christiansen, S.

AU - Elmelund, E.

AU - Holmer, M. L.

AU - Damdimopoulou, P.

AU - Panagiotou, E. M.

AU - van Duursen, M.

AU - Bouftas, N.

AU - Svingen, T.

AU - Beronius, A.

PY - 2023

Y1 - 2023

U2 - 10.1016/S0378-4274(23)00453-8

DO - 10.1016/S0378-4274(23)00453-8

M3 - Conference abstract in journal

SN - 0378-4274

VL - 384

SP - S77

JO - Toxicology Letters

JF - Toxicology Letters

IS - Supplement 1

M1 - P01-10

ER -